Keel Point, LLC Pfizer Inc Transaction History

Keel Point, LLC

$1.12 Billion
Q2 2024

A detailed history of Keel Point, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Keel Point, LLC holds 14,169 shares of PFE stock, worth $378,595. This represents 0.04% of its overall portfolio holdings.

Number of Shares

14,169

Holding current value

$378,595

% of portfolio

0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $357,908 - $419,402	14,169 New	14,169 $396,000
Q4 2023 Jan 30, 2024	BUY	$26.13 - $33.94 $186,881 - $242,738	7,152 New	7,152 $205,000
Q2 2023 Jul 12, 2023	BUY	$36.12 - $41.79 $52,482 - $60,720	1,453 Added 19.09%	9,066 $332,000
Q1 2023 Apr 03, 2023	SELL	$39.39 - $51.28 $85,279 - $111,021	-2,165 Reduced 22.14%	7,613 $310,000
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $46,259 - $60,386	-1,108 Reduced 10.18%	9,778 $0
Q3 2022 Oct 05, 2022	BUY	$43.76 - $53.42 $7,964 - $9,722	182 Added 1.7%	10,886 $476,000
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $43,552 - $51,639	936 Added 9.58%	10,704 $535,000
Q1 2022 Apr 27, 2022	BUY	$45.75 - $56.69 $104,081 - $128,969	2,275 Added 30.36%	9,768 $506,000
Q4 2021 Jan 31, 2022	BUY	$41.32 - $61.25 $21,982 - $32,585	532 Added 7.64%	7,493 $442,000
Q3 2021 Nov 04, 2021	BUY	$39.25 - $50.42 $208,260 - $267,528	5,306 Added 320.6%	6,961 $299,000
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $156,028 - $176,754	-4,345 Reduced 72.42%	1,655 $1.82 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $200,940 - $226,620	6,000 New	6,000 $217,000
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $232,646 - $282,234	-7,724 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$27.03 - $38.62 $2,648 - $3,784	98 Added 1.29%	7,724 $252,000
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $26,434 - $30,000	803 Added 11.77%	7,626 $299,000
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $162 - $210	5 Added 0.07%	6,823 $245,000
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $3,661 - $4,110	-99 Reduced 1.43%	6,818 $295,000
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $101,475 - $111,487	-2,706 Reduced 28.12%	6,917 $294,000
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $50,818 - $57,939	-1,321 Reduced 12.07%	9,623 $420,000
Q3 2018 Nov 07, 2018	SELL	$34.47 - $41.81 $18,820 - $22,828	-546 Reduced 4.75%	10,944 $482,000
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $3,429 - $3,656	104 Added 0.91%	11,490 $417,000
Q1 2018 May 07, 2018	SELL	$31.91 - $37.02 $6,445 - $7,478	-202 Reduced 1.74%	11,386 $404,000
Q4 2017 Feb 08, 2018	SELL	$33.26 - $35.29 $174,315 - $184,954	-5,241 Reduced 31.14%	11,588 $420,000
Q3 2017 Nov 09, 2017	SELL	$31.0 - $34.15 $60,636 - $66,797	-1,956 Reduced 10.41%	16,829 $601,000
Q2 2017 Aug 15, 2017	BUY	N/A	18,785	18,785 $631,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$13.7 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.67 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.44 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.13 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.

Account